These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18511249)

  • 21. Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in mice.
    Mekontso-Dessap A; Brouri F; Pascal O; Lechat P; Hanoun N; Lanfumey L; Seif I; Benhaiem-Sigaux N; Kirsch M; Hamon M; Adnot S; Eddahibi S
    Circulation; 2006 Jan; 113(1):81-9. PubMed ID: 16380550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bromocriptine use and the risk of valvular heart disease.
    Tan LC; Ng KK; Au WL; Lee RK; Chan YH; Tan NC
    Mov Disord; 2009 Feb; 24(3):344-9. PubMed ID: 18989898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin receptor 2B signaling with interstitial cell activation and leaflet remodeling in degenerative mitral regurgitation.
    Driesbaugh KH; Branchetti E; Grau JB; Keeney SJ; Glass K; Oyama MA; Rioux N; Ayoub S; Sacks MS; Quackenbush J; Levy RJ; Ferrari G
    J Mol Cell Cardiol; 2018 Feb; 115():94-103. PubMed ID: 29291394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of 5-HT
    Ayme-Dietrich E; Lawson R; Côté F; de Tapia C; Da Silva S; Ebel C; Hechler B; Gachet C; Guyonnet J; Rouillard H; Stoltz J; Quentin E; Banas S; Daubeuf F; Frossard N; Gasser B; Mazzucotelli JP; Hermine O; Maroteaux L; Monassier L
    Br J Pharmacol; 2017 Nov; 174(22):4123-4139. PubMed ID: 28806488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonergic activation of 5HT1A and 5HT2 receptors modulates sexually dimorphic communication signals in the weakly electric fish Apteronotus leptorhynchus.
    Smith GT; Combs N
    Horm Behav; 2008 Jun; 54(1):69-82. PubMed ID: 18336816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperserotonemia in autism: the potential role of 5HT-related gene variants.
    Hranilović D; Novak R; Babić M; Novokmet M; Bujas-Petković Z; Jernej B
    Coll Antropol; 2008 Jan; 32 Suppl 1():75-80. PubMed ID: 18405062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyproheptadine prevents pergolide-induced valvulopathy in rats: an echocardiographic and histopathological study.
    Droogmans S; Roosens B; Cosyns B; Degaillier C; Hernot S; Weytjens C; Garbar C; Caveliers V; Pipeleers-Marichal M; Franken PR; Lahoutte T; Schoors D; Van Camp G
    Am J Physiol Heart Circ Physiol; 2009 Jun; 296(6):H1940-8. PubMed ID: 19346455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine agonists and valvular heart disease.
    Cheung D; Heaney A
    Curr Opin Endocrinol Diabetes Obes; 2009 Aug; 16(4):316-20. PubMed ID: 19506475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fenfluramine disrupts the mitral valve interstitial cell response to serotonin.
    Connolly JM; Bakay MA; Fulmer JT; Gorman RC; Gorman JH; Oyama MA; Levy RJ
    Am J Pathol; 2009 Sep; 175(3):988-97. PubMed ID: 19679875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lisuride, a dopamine receptor agonist with 5-HT2B receptor antagonist properties: absence of cardiac valvulopathy adverse drug reaction reports supports the concept of a crucial role for 5-HT2B receptor agonism in cardiac valvular fibrosis.
    Hofmann C; Penner U; Dorow R; Pertz HH; Jähnichen S; Horowski R; Latté KP; Palla D; Schurad B
    Clin Neuropharmacol; 2006; 29(2):80-6. PubMed ID: 16614540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serotonin transporter kinetics in rats selected for extreme values of platelet serotonin level.
    Cicin-Sain L; Froebe A; Bordukalo-Niksic T; Jernej B
    Life Sci; 2005 Jun; 77(4):452-61. PubMed ID: 15894014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonergic drugs and valvular heart disease.
    Rothman RB; Baumann MH
    Expert Opin Drug Saf; 2009 May; 8(3):317-29. PubMed ID: 19505264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease.
    Lane EL; Brundin P; Cenci MA
    Neurobiol Dis; 2009 Jul; 35(1):42-51. PubMed ID: 19361557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo model of drug-induced valvular heart disease in rats: pergolide-induced valvular heart disease demonstrated with echocardiography and correlation with pathology.
    Droogmans S; Franken PR; Garbar C; Weytjens C; Cosyns B; Lahoutte T; Caveliers V; Pipeleers-Marichal M; Bossuyt A; Schoors D; Van Camp G
    Eur Heart J; 2007 Sep; 28(17):2156-62. PubMed ID: 17636306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of the galaninergic system in modulating stress-related responses in an animal model of posttraumatic stress disorder.
    Kozlovsky N; Matar MA; Kaplan Z; Zohar J; Cohen H
    Biol Psychiatry; 2009 Mar; 65(5):383-91. PubMed ID: 19095221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased aortic contractile reaction to 5-hydroxytryptamine in rats with long-term hypertension induced by lead (Pb(2+)) exposure.
    Zhang LF; Peng SQ; Wang S
    Toxicol Lett; 2009 Apr; 186(2):78-83. PubMed ID: 19167473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MDMA treatment 6 months earlier attenuates the effects of CP-94,253, a 5-HT1B receptor agonist, on motor control but not sleep inhibition.
    Gyongyosi N; Balogh B; Kirilly E; Kitka T; Kantor S; Bagdy G
    Brain Res; 2008 Sep; 1231():34-46. PubMed ID: 18638459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonergic modulation of pain and analgesic responses: a study in rats with constitutionally altered serotonin transporters.
    Kesic M; Tvrdeic A; Kolaric D; Stojkovic R; Cicin-Sain L
    Eur J Pain; 2015 Apr; 19(4):508-15. PubMed ID: 25070859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The challenge of defining normality for human mitral and aortic valves: geometrical and compositional analysis.
    McDonald PC; Wilson JE; McNeill S; Gao M; Spinelli JJ; Rosenberg F; Wiebe H; McManus BM
    Cardiovasc Pathol; 2002; 11(4):193-209. PubMed ID: 12140125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibody targeting of fibroblast growth factor receptor 1c causes cardiac valvulopathy in rats.
    Buss N; Lapointe JM; de Haan L; Price S; Ahnmark A; Irving L; Buchanan A; Keyes F; Davidsson P; Dixit R; Lindén D
    Toxicol Appl Pharmacol; 2018 Sep; 355():147-155. PubMed ID: 30008375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.